MLERFi Awards $980,000 in Research Grants

MLERFi Awards $980,000 in Research Grants

July 21, 2016. MLERFi Immediate Past President Randall “Randy” Pinch announced the recipients of the 2014-2015 MLERFi grants. Through the fund-raising efforts of Lions throughout Massachusetts, MLERF was able to distribute $980,000 to Boston area research institutions. Grants were awarded to the following institutions: Boston University Medical Center($170,000) Boston Children’s Hospital($140,000) Tufts University Medical Center($170,000) … Continue reading

Using Retinal Stem Cells to Restore Vision

Using Retinal Stem Cells to Restore Vision

Here’s a great video explaining how retinal stem cells (aka retinal precursor cells) are used to restore vision: Retinal precursor cells are biological cells that differentiate into the various cell types of the retina during development. In the vertebrate, these retinal cells differentiate into seven cell types, including retinal ganglion cells,amacrine cells, bipolar cells, horizontal … Continue reading

New Instrument Provides Instant Results

New Instrument Provides Instant Results

The New England Eye Center sees nearly 10,000 patients diagnosed with corneal disease every year. It can take anywhere from a few days to a few weeks to diagnose and begin treatment for corneal infections. The standard diagnostic procedure involves taking a biopsy of corneal tissue. Then waiting for the results from a pathologist. What … Continue reading

Success Story: FDA Approved Drug Treatment for AMD

Embed from Getty Images An FDA Approved Drug Treatment For Age Related Macular Degeneration (AMD). Studies undertaken by Massachusetts Eye and Ear Infirmary researchers led to the first FDA-approved drug treatment for neovascular AMD: photodynamic therapy (PDT) with Visudyne®, a combination laser/drug therapy. Now over a decade in use, Visudyne® was a revolution in patient … Continue reading

Success Story: New Gene Therapy for Dry AMD

Success Story: New Gene Therapy for Dry AMD

With support from MLERFi, researchers at Tufts University School of Medicine have developed a new gene therapy that will be tested in human patients In 2016. Specifically, this therapy will target the ‘dry’ form of AMD that currently accounts for 90% of AMD patients, none of whom can be currently treated. This gene therapy uses … Continue reading